Logo

Business

NSE files papers for Rs 30,000-crore IPO

The National Stock Exchange (NSE) filed a draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on Wednesday, June 17, according to official documents.

Samsung Biologics plans to separate CDMO, biosimilar biz

Samsung Biologics, a biotech arm of South Korea's Samsung Group, said on Thursday it plans to spin off its biosimilar development business to streamline its operations and focus on its core contract development and manufacturing organisation (CDMO) services.